Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2013 Mar;56(3):316-9.
doi: 10.1097/MPG.0b013e3182758c4a.

Blood lead concentration is not altered by high-dose vitamin D supplementation in children and young adults with HIV

Affiliations
Randomized Controlled Trial

Blood lead concentration is not altered by high-dose vitamin D supplementation in children and young adults with HIV

Veronique Groleau et al. J Pediatr Gastroenterol Nutr. 2013 Mar.

Abstract

Objectives: Optimal vitamin D status is known to have beneficial health effects and vitamin D supplements are commonly used. It has been suggested that vitamin D supplementation may increase blood lead in children and adults with previous lead exposure. The objective was to determine the safety regarding lead toxicity during 12 weeks of high-dose vitamin D3 supplementation in children and young adults with human immunodeficiency virus (HIV).

Methods: Subjects with HIV (8-24 years) were randomized to vitamin D3 supplementation of 4000 or 7000 IU/day and followed at 6 and 12 weeks for changes in serum 25-hydroxy vitamin D (25D) and whole-blood lead concentration. This was a secondary analysis of a larger study of vitamin D3 supplementation in children and adolescents with HIV.

Results: In 44 subjects (75% African American), the baseline mean ± standard deviation serum 25D was 48.3±18.6 nmol/L. Fifty percent of subjects had baseline serum 25D <50.0 nmol/L. Serum 25D increased significantly with D3 supplementation during the 12 weeks. No subject had a whole-blood lead >5.0 μg/dL at baseline or during subsequent visits. Whole-blood lead and 25D were not correlated at baseline, and were negatively correlated after 12 weeks of supplementation (P=0.014). Whole-blood lead did not differ between those receiving 4000 and 7000 IU of vitamin D3.

Conclusions: High-dose vitamin D3 supplementation and the concomitant increased serum 25D did not result in increased whole-blood lead concentration in this sample of children and young adults living in a northeastern urban city.

Trial registration: ClinicalTrials.gov NCT01092338.

PubMed Disclaimer

Conflict of interest statement

The authors declare they have no or potential competing financial interest.

Figures

Figure 1
Figure 1
Whole blood lead level is presented over time (0 = baseline, 6 = 6 weeks, 12 = 12 weeks) separately by age group: age 8 to 12.9, age 13 to 18.9 and age 19 to 24.9. The horizontal lines represent the median values in blood lead level. The Figure shows a higher whole blood lead throughout the study in the youngest age group compared to both older age groups (p ≤ 0.02).

References

    1. Herr C, Greulich T, Koczulla RA, et al. The role of vitamin D in pulmonary disease: COPD, asthma, infection and cancer. Respir Res. 2011;12:31. - PMC - PubMed
    1. Bischoff-Ferrari HA, Dawson-Hughs B, Stocklin E, et al. Oral supplementation with 25(OH)D(3) versus vitamin D(3): effects on 25(OH)D levels, lower extremity function, blood pressure and markers of innate immunity. J Bone Miner Res. 2011 doi: 10.1002/jbmr.551. Online 25 October 2011. - DOI - PubMed
    1. Jackson RD, LaCroix AZ, Gass M, et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med. 2006;354(7):669–83. - PubMed
    1. Spector SA. Vitamin D and HIV: letting the sun shine in. Top Antivir Med. 2011;19(1):6–10. - PMC - PubMed
    1. Wintergerst ES, Maggini S, Hornig DH. Contribution of selected vitamins and trace elements to immune function. Ann Nutr Metab. 2007;51(4):301–23. - PubMed

Publication types

MeSH terms

Associated data